P. Nyländen

Valproic acid combined with 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 in the treatment of patients with myelodysplastic syndromes.

P. Koistinen, T. Siitonen, E. Savolainen, 2007, Haematologica.

Treatment of multiple myeloma in old patients

B. Isomaa, M. Kääriäinen, C. Wasastjerna, 1989 .

Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function

S. Laakso, M. Anttila, E. Sotaniemi, 1995, Clinical pharmacology and therapeutics.

Intensive chemotherapy with combinations containing anthracyclines for refractory and relapsing multiple myeloma

B. Isomaa, E. Elonen, T. Pulli, 1990, European journal of haematology.

Treatment of multiple myeloma with an intensive 5‐drug combination or intermittent melphalan and prednisone; a randomised multicentre trial

B. Isomaa, T. Pulli, C. Wasastjerna, 1987 .

Corticosteroid is not beneficial in multiple‐drug combination chemotherapy for multiple myeloma

B. Isomaa, P. Koistinen, E. Elonen, 1993, European journal of haematology.

Effect of the Choice of Primary Chemotherapy on the Cumulative Length of Stay in Hospital for Multiple Myeloma.

B. Isomaa, C. Wasastjerna, H. Mäkelä, 1990, Leukemia and Lymphoma.

Rate of Kidney Function Decline is Associated With Kidney and Heart Failure in Individuals With Type 1 Diabetes

T. Vatanen, I. Vauhkonen, M. Honkala, 2023, Kidney international reports.